Novo Integrated Sciences Stock Net Income
| NVOS Stock | USD 0 0.00 0.000005% |
Fundamental analysis of Novo Integrated allows traders to better anticipate movements in Novo Integrated's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Loss | -11.9 M | -11.3 M | |
| Net Loss | -11.9 M | -11.3 M | |
| Net Loss | -4 M | -3.8 M | |
| Net Loss | (0.74) | (0.77) | |
| Net Income Per E B T | 1.15 | 1.12 |
Novo | Net Income | Build AI portfolio with Novo Stock |
Novo Integrated Sciences Company Net Income Analysis
Novo Integrated's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Novo Integrated Net Income | (13.27 M) |
Most of Novo Integrated's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novo Integrated Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Novo Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Novo Integrated is extremely important. It helps to project a fair market value of Novo Stock properly, considering its historical fundamentals such as Net Income. Since Novo Integrated's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Novo Integrated's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Novo Integrated's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Novo Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Novo Integrated Sciences reported net income of (13.27 Million). This is 103.89% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.32% higher than that of the company.
Novo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in net income category among its peers.
Novo Integrated Institutional Holders
Institutional Holdings refers to the ownership stake in Novo Integrated that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Novo Integrated's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Novo Integrated's value.| Shares | Advisor Group Holdings, Inc. | 2025-03-31 | 0.0 |
Novo Fundamentals
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.22) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 3 M | ||||
| Shares Outstanding | 19.73 M | ||||
| Shares Owned By Insiders | 6.58 % | ||||
| Number Of Shares Shorted | 274.86 K | ||||
| Price To Book | 0 X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 13.29 M | ||||
| Gross Profit | 5.74 M | ||||
| EBITDA | (10.08 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.71 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.78 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (1.33) X | ||||
| Number Of Employees | 115 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 41.43 K | ||||
| Total Asset | 32.14 M | ||||
| Retained Earnings | (83.2 M) | ||||
| Working Capital | (3.52 M) | ||||
| Net Asset | 32.14 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novo Stock Analysis
When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.